Acquired encephalopathy associated with carnitine deficiency after cefditoren pivoxil administration

被引:17
作者
Kim, Heyun [1 ]
Chu, Kon [2 ]
Jung, Keun-Hwa [2 ]
Lee, Soon-Tae [2 ]
Kim, Jeong-Min [2 ]
Lee, Sang Kun [2 ]
机构
[1] Kwandong Univ, Dept Neurol, Coll Med, MyongjiHosp, Gyeonggi Do, South Korea
[2] Seoul Natl Univ Hosp, Dept Neurol, Lab Neurotherapeut, Comprehens Epilepsy Ctr,Biomed Res Inst, Seoul 110744, South Korea
关键词
Encephalopathy; Carnitine deficiency; Diffusion magnetic resonance imaging;
D O I
10.1007/s10072-012-0939-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We describe a 47-year-old woman who presented with palinopsia and subacute altered mental change after cefditoren pivoxil administration. The patient showed characteristic clinical manifestations of hypocarnitinemia, which affected her state of consciousness and she had radiologic findings that revealed metabolic encephalopathy with cytotoxic edema in the right occipital area and intracranial hemorrhages in right occipital and left frontal areas. Follow-up imaging after oral carnitine supplementation demonstrated complete resolution of the bilateral frontal subcortical T2 high-intensity lesions. Carnitine deficiency due to cefditoren pivoxil treatment may present as metabolic encephalopathy in adults. This possibility should be considered with the differential diagnosis of encephalopathies, and carnitine levels should be checked in patients treated with cefditoren pivoxil.
引用
收藏
页码:1393 / 1396
页数:4
相关论文
共 11 条
[1]   VALPROATE ENCEPHALOPATHY AND HYPOCARNITINAEMIA IN DIABETIC-PATIENTS [J].
AVERBUCHHELLER, L ;
BENHUR, T ;
RECHES, A .
JOURNAL OF NEUROLOGY, 1994, 241 (09) :567-569
[2]   Brain magnetic resonance in the diagnostic evaluation of mitochondrial encephalopathies [J].
Bianchi, Maria Cristina ;
Sgandurra, Giuseppina ;
Tosetti, Michela ;
Battini, Roberta ;
Cioni, Giovanni .
BIOSCIENCE REPORTS, 2007, 27 (1-3) :69-85
[3]  
HOLME E, 1989, LANCET, V2, P469
[4]   ALTERATION OF AMMONIA AND CARNITINE LEVELS IN SHORT-TERM TREATMENT WITH PIVALIC ACID-CONTAINING PRODRUG [J].
ITO, T ;
SUGIYAMA, N ;
KOBAYASHI, M ;
KIDOUCHI, K ;
ITOH, T ;
UEMURA, O ;
SUGIYAMA, K ;
TOGARI, H .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 175 (01) :43-53
[5]   Science review: Carnitine in the treatment of valproic acid-induced toxicity - what is the evidence? [J].
Lheureux, PER ;
Penaloza, A ;
Zahir, S ;
Gris, M .
CRITICAL CARE, 2005, 9 (05) :431-440
[6]   Determination of the reference range of endogenous plasma carnitines in healthy adults [J].
Reuter, Stephanie E. ;
Evans, Allan M. ;
Chace, Donald H. ;
Fornasini, Gianfranco .
ANNALS OF CLINICAL BIOCHEMISTRY, 2008, 45 :585-592
[7]   SUBNORMAL CARNITINE LEVELS AND THEIR CORRECTION IN ARTIFICIALLY FED PATIENTS FROM A NEUROLOGICAL INTENSIVE-CARE UNIT - A PILOT-STUDY [J].
SCHAFER, J ;
REICHMANN, H .
JOURNAL OF NEUROLOGY, 1990, 237 (03) :213-215
[8]   Carnitine deficiency disorders in children [J].
Stanley, CA .
CARNITINE: THE SCIENCE BEHIND A CONDITIONALLY ESSENTIAL NUTRIENT, 2004, 1033 :42-51
[9]   Interaction between pivaloylcarnitine and L-carnitine transport into L6 cells overexpressing hOCTN2 [J].
Todesco, Liliane ;
Bodmer, Michael ;
Vonwil, Karin ;
Haeussinger, Daniel ;
Kraehenbuehl, Stephan .
CHEMICO-BIOLOGICAL INTERACTIONS, 2009, 180 (03) :472-477
[10]  
Virmani Ashraf, 2004, Molecular Aspects of Medicine, V25, P533, DOI 10.1016/j.mam.2004.06.003